AMGN monthly performance report
Check AMGN's monthly returns, drawdown, and seasonality trends — updated every month.
AMGN monthly report
—
Key takeaways
- Amgen (AMGN) closed September 2026 at $385.65, down 10.29% for the month and +39.81% over the trailing 12 months.
- Year-to-date, AMGN is +17.82%, outperforming the S&P 500 which has returned +11.70% YTD.
- The stock is trading +7.43% versus its 200-day moving average ($358.99), a bullish technical signal.
- Over the past three years, AMGN has underperformed the S&P 500 by −25.14%, with a relative strength index reading of 85.4.
- Win rate over the trailing 39 months stands at 56.4% — 22 positive months versus 17 negative months.
Amgen ended September 2026 at $385.65, posting a monthly return of −10.29%. The S&P 500 returned −0.70% over the same window, leaving relative performance at −9.59%.
The current quarter stands at +6.50% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +7.43% versus the 200-day moving average ($358.99).
Year-to-date, AMGN is +17.82% against SPY +11.70%, a gap of +6.13%. The stock is currently −13.73% below its 52-week high, with maximum 3-year drawdown at −23.35%.
| Period | AMGN | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +1.55% | −0.12% | +1.66% |
| 1 Week | +2.20% | −0.34% | +2.54% |
| 1 Month | −10.29% | −0.70% | −9.59% |
| 3 Months | +10.02% | +2.80% | +7.22% |
| 6 Months | +4.86% | +13.85% | −8.99% |
| YTD | +17.82% | +11.70% | +6.13% |
| 12 Months | +39.81% | +15.01% | +24.80% |
| 3 Years | +46.55% | +71.69% | −25.14% |
| Rank | Month | Return |
|---|---|---|
| #1 | Nov 2025 | +15.76% |
| #2 | Feb 2026 | +13.54% |
| #3 | May 2024 | +11.65% |
| #4 | Aug 2026 | +11.61% |
| #5 | Jan 2025 | +9.51% |
| Rank | Month | Return |
|---|---|---|
| #1 | Feb 2024 | −12.87% |
| #2 | Nov 2024 | −11.65% |
| #3 | Sep 2026 | −10.29% |
| #4 | Mar 2026 | −9.35% |
| #5 | Dec 2024 | −7.86% |
| Quarter | Return |
|---|---|
| Q2 2025 | −10.38% |
| Q3 2025 | +1.07% |
| Q4 2025 | +15.99% |
| Q1 2026 | +7.50% |
| Q2 2026 | +2.92% |
| Q3 2026 (QTD) | +6.50% |
| Year | Return |
|---|---|
| 2023 | +9.66% |
| 2024 | −9.51% |
| 2025 | +25.58% |
| 2026 | +17.82% |
| Metric | Value |
|---|---|
| 52-Week High | $447.03 (2026-08-25) |
| 52-Week Low | $269.77 (2025-09-26) |
| Current Price | $385.65 |
| 200-Day Moving Average | $358.99 |
| Price vs 200DMA | +7.43% |
| 3-Year Maximum Drawdown | −23.35% (2025-01-06) |
| Current Drawdown from 52W High | −13.73% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 85.4 |
| 3-Year Excess Return vs S&P 500 | −25.14% |
| RS Peak | 111.8 (Feb 2024) |
| RS Trough | 69.5 (Sep 2025) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was AMGN's return for this report period?
AMGN returned −10.29% in the latest monthly window ending 2026-09-18.
Has AMGN outperformed SPY year to date?
YTD AMGN: +17.82% vs SPY: +11.70%.
What is AMGN's 12-month return?
+39.81% over the trailing 12 months.
Is AMGN above or below its 200-day moving average?
Price is +7.43% versus 200DMA ($358.99).
What is the maximum drawdown in the 3-year window?
−23.35% on 2025-01-06.